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Editors: Anton N. Sidawy and Bruce A. PerlerAortic neck enlargement after endovascular aneurysm
repair using balloon-expandable versus self-expanding
endografts
Janis Savlovskis, MD, Dainis Krievins, MD, PhD, Jean-Paul
P. M. de Vries, MD, PhD, Andrew Holden, MD, Kaspars Kisis,
MD, Marcis Gedins, MD, Natalija Ezite, MD, and Christopher
K. Zarins, MD
Objective: This study evaluated changes in aortic neck
diameter after endovascular aneurysm repair (EVAR) using a
balloon-expandable stent (BES) endograft compared with a
commercially available self-expanding stent (SES) endograft.
We hypothesized that forces applied to the aortic neck by
SES endografts may induce aortic neck enlargement over
time and that such enlargement may not occur in aneurysm
patients treated with a device that does not use a proximal
SES.
Methods: This was a retrospective quantitative computed
tomography (CT) image analysis of patients treated with the
Nellix (Endologix, Irvine, Calif) BES (n = 49) or the Endurant
II (Medtronic, Minneapolis, Minn) SES (n = 56) endograft
from 2008 to 2010. Patients with preimplant, postimplant,
and at least 1-year serial CT scans underwent quantitative
morphometric assessment by two independent vascular
radiologists blinded to the outcome results. Changes in the
infrarenal neck over time were compared with the supra-
renal aorta for each patient.
Results: Follow-up extended to 4.8 years for the BES and to
4.6 years for the SES, with no signiﬁcant difference in
median follow-up time (34 months for BESs and 24 months
for SESs; P = .06). There were no differences in preimplant
neck diameter (25.2  0.9 mm vs 25.7  1.1 mm; P = .54)
or length (27.7  3.7 mm vs 23.6  3.7 mm; P = .12)
between BESs and SESs at baseline. After implantation, neck
diameter increased by 1.1  0.5 mm in BES patients and 2.6
 0.5 mm in SES patients (P = .07) compared with the
preoperative diameter. At 3 years, neck diameter increased
by 0.5  0.9 mm in BES patients and by 3.8  1.0 mm in
SES patients (P = .0002) compared with the ﬁrst post-
operative CT scan. The annual postimplant rate of increase
in the infrarenal neck diameter was ﬁvefold greater in SES
patients (1.1  0.1 mm/y) than in BES patients (0.22  0.04
mm/y; P < .0001). There were no signiﬁcant differences in
the diameter of the suprarenal aorta at baseline or at 3
years and no differences in the annual rate of change in*Full articles available online at www.jvascsurg.org
1078-5884/
http://dx.doi.org/10.1016/S1078-5884(15)00580-8suprarenal aortic diameter between BES and SES
endografts.
Conclusions: EVAR using SES endografts resulted in pro-
gressive infrarenal aortic neck enlargement, whereas EVAR
using BES endografts resulted in no neck enlargement over
time. These data suggest that infrarenal neck enlargement
after EVAR with SES endografts is likely related to the force
exerted by SES elements rather than disease progression in
the infrarenal neck.The impact of endovascular repair on specialties
performing abdominal aortic aneurysm repair
Klaas H. J. Ultee, BSc, Rob Hurks, MD, PhD, Dominique B.
Buck, MD, George S. DaSilva, BS, Peter A. Soden, MD, Joost
A. van Herwaarden, MD, PhD, Hence J. M. Verhagen, MD,
PhD, and Marc L. Schermerhorn, MD
Background: Abdominal aortic aneurysm (AAA) repair has
been performed by various surgical specialties for many
years. Endovascular aneurysm repair (EVAR) may be a dis-
ruptive technology, having an impact on which specialties
care for patients with AAA. Therefore, we examined the
proportion of AAA repairs performed by various specialties
over time in the United States and evaluated the impact of
the introduction of EVAR.
Methods: The Nationwide Inpatient Sample (2001-2009)
was queried for intact and ruptured AAA and for open
repair and EVAR. Speciﬁc procedures were used to identify
vascular surgeons (VSs), cardiac surgeons (CSs), and general
surgeons (GSs) as well as interventional cardiologists and
interventional radiologists for states that reported unique
treating physician identiﬁers. Annual procedure volumes
were subsequently calculated for each specialty.
Results: We identiﬁed 108,587 EVARs and 85,080 open AAA
repairs (3011 EVARs and 12,811 open repairs for ruptured
AAA). VSs performed an increasing proportion of AAA
repairs during the study period (52% in 2001 to 66% in
2009; P < .001). GSs and CSs performed fewer repairs
during the same period (25% to 17% [P < .001] and 19% to
13% [P < .001], respectively). EVAR was increasingly used
for intact (33% to 78% of annual cases; P < .001) as well as
ruptured AAA repair (5% to 28%; P < .001). The proportion
of intact open repairs performed by VSs increased from 52%
to 65% (P < .001), whereas for EVAR, the proportion went
from 60% to 67% (P < .001). The proportion performed by
VSs increased for ruptured open repairs from 37% to 53% (P
< .001) and for ruptured EVARs from 28% to 73% (P <
.001). Compared with treatment by VSs, treatment by a CS
406 Abstracts(0.55 [0.53-0.56]) and GS (0.66 [0.64-0.68]) was associated
with a decreased likelihood of undergoing endovascular
rather than open AAA repair.
Conclusions: VSs are performing an increasing majority of
AAA repairs, in large part driven by the increased utilization
of EVAR for both intact and ruptured AAA repair. However,
GSs and CSs still perform AAA repair. Further studies should
examine the implications of these national trends on the
outcome of AAA repair.Patency of renal and visceral vessels after open
thoracoabdominal aortic replacement
Marwan Youssef, MD, Achim Neufang, MD, PhD, Florian
Jungmann, MD, Christian-Friedrich Vahl, MD, PhD, and
Bernhard Dorweiler, MD, PhD
Objective: In thoracoabdominal aortic aneurysms (TAAAs),
a paradigm shift is observed from open surgery toward total
endovascular aortic repair using fenestrated and branched
endografts. Whereas outcome after open replacement in
terms of mortality and paraplegia has been evaluated
extensively, no studies exist addressing long-term patency
of visceral and renal vessels. To enable comparison of target
vessel patency between open and endovascular treatment,
we analyzed our series of open TAAA replacements.
Methods: Our vascular surgery database was screened for
patients who received open TAAA replacement between
1998 and 2012, and patient records were analyzed retro-
spectively. All available imaging scans (computed tomog-
raphy and magnetic resonance angiography: preoperative,
postoperative, and follow-up) were evaluated for graft and
vessel patency.
Results: We identiﬁed 62 patients (mean age, 66  10
years; 40 men) who had been operated on for aneurysms of
Crawford types I (8), II (13), III (13), and IV (24) and Saﬁ type
V (4). A total of 181 vessels were revascularized by either
patch inclusion (n = 147) or selective revascularization
(bypass or transposition, n = 34); 48 survived the procedure,
resulting in a number of vessels available for follow-up of
154 (patch, 126; selective revascularization, 28). The
respective patency rates for overall, patch, and selective
revascularization were 95.2%, 94.2%, and 100% at 5 years
and 83.7%, 81.3%, and 100% at 10 years, respectively. In
addition, a trend for better performance of selective
revascularization (bypass or transposition) was evident as
all vessel occlusions were observed in cases of patch
inclusion, whereas all selectively revascularized vessels
were patent. The respective patency rates for the celiac
trunk, superior mesenteric artery, and left and right renal
artery were 100%, 97.5%, 92.3%, and 90.3% at 5 years.
Conclusions: In our series of open thoracoabdominal aortic
replacement, excellent patency rates for revascularized
renal and visceral vessels were observed during long-term
follow-up. We were able to provide a reference value of
long-term target vessel patency that can and should betaken into account to judge the efﬁcacy of endovascular
repair in TAAA.Carotid artery stenting may be performed safely in
patients with radiation therapy-associated carotid stenosis
without increased restenosis or target lesion
revascularization
Reid A. Ravin, MD, Armand Gottlieb, BS, Kyle Pasternac, BS,
Neal Cayne, MD, Darren Schneider, MD, Prakash Krishnan,
MD, Michael Marin, MD, and Peter L. Faries, MD
Objective: Neck radiation therapy (XRT) can induce carotid
artery stenosis and may increase the technical difﬁculty of
endarterectomy. It is considered a relative indication for
carotid angioplasty and carotid artery stenting (CAS). This
study sought to evaluate differences in CAS embolic
potential and restenosis performed on XRT and non-XRT
patients.
Methods: At three institutions, 366 CAS procedures were
performed on 321 patients (XRT, n = 43; non-XRT, n = 323).
Mean follow-up was 410 days (median, 282 days; range, 7-
1920 days). Patients were observed with duplex ultrasound
to assess for restenosis. Additional end points included
target lesion revascularization (TLR), myocardial and cere-
brovascular events, and perioperative complications. Cap-
tured particulate from embolic protection ﬁlters was
analyzed with photomicroscopy and image analysis soft-
ware for 27 XRT and 214 non-XRT ﬁlters.
Results: XRT patients were more likely to be male and had
lower rates of hypertension, coronary artery disease, and
diabetes mellitus, although the mean age at procedure did
not differ. There was no increase in severe internal carotid
tortuosity among XRT patients (XRT: 50% vs non-XRT:
34.7%; P = .06). Indication for CAS did not differ between
the two groups, including the number of CAS procedures
performed for symptomatic carotid stenosis (XRT: 39.7% vs
non-XRT: 39.0%; P = NS). Perioperative outcomes, including
the composite 30-day stroke, myocardial infarction, and
mortality, were not signiﬁcantly different (XRT: 2.6% vs
non-XRT: 3.9%; P = NS.) There were no signiﬁcant differ-
ences in restenosis rate at the 50% (XRT: 9.4% vs non-XRT:
8.6%; P = NS) or 70% (XRT: 3.5% vs non-XRT: 8.6%; P = NS)
threshold. Filter particle analysis revealed that ﬁlters from
XRT patients had more numerous large particles per ﬁlter
(1.4 vs 0.7; P < .05) and larger mean particle size (464.1
mm vs 320.0 mm; P < .05). TLR did not differ signiﬁcantly
between the groups.
Conclusions: In contrast to earlier studies, this analysis
reveals that there are signiﬁcant differences in XRT and non-
XRT patients undergoing CAS in terms of medical comor-
bidities and embolic material captured in embolic pro-
tection ﬁlters. The decreased incidence of atherosclerotic
risk factors was observed in XRT patients probably because
XRT was the primary factor responsible for carotid stenosis.
Despite increased embolic particle size, CAS can be
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restenosis in XRT patients.The effect of demographic factors and lesion severity on
iliac stent patency
Amy N. Roach, BS, Sebastian Larion, MS, Sadaf S. Ahanchi,
MD, Chad P. Ammar, MD, Colin T. Brandt, MD, David J.
Dexter, MD, and Jean M. Panneton, MD
Objective: The aim of our study was to perform a large
multivariate analysis to identify demographic, anatomic, or
procedural factors that affect iliac artery stent primary
patency (PP).
Methods: Patients receiving iliac stents from 2007 to 2013
were retrospectively reviewed. Univariate analysis assessed
cohort characteristics and their effect on PP. Variables
considered signiﬁcant (P < .05) were brought forward in the
multivariate analysis.
Results: A total of 213 patients underwent primary iliac
artery stenting, and 307 limbs were analyzed. The average
age was 66 years (range, 38-93 years), 54% were male, and
55% were Caucasian. Indications for procedure were clau-
dication in 68%, rest pain in 20%, and tissue loss in 12%.
All TransAtlantic Inter-Society Consensus for the Manage-
ment of Peripheral Arterial Disease (TASC) II classiﬁcations
were included: 51% TASC II A, 25% TASC II B, 13% TASC II
C, and 11% TASC II D. The treated anatomic locations were
27% isolated external iliac artery (EIA), 56% isolated com-
mon iliac artery, and 17% combined common iliac artery
and EIA. Multivariate analysis found three factors were
correlated with decreased PP: non-Caucasian race (hazard
ratio [HR], 1.84; 95% conﬁdence interval [CI], 1.08-3.13; P =
.025), younger age (HR, 1.04; 95% CI, 1.01-1.08; P = .006),
and presence of EIA occlusion (HR, 2.02; 95% CI, 1.05-3.89;
P = .036). Overall, Kaplan-Meier analysis at 1 and 3 years
revealed a PP of 86% and 53%, assisted PP of 98% and
89%, and secondary patency of 99% of 98%. Kaplan-Meier
analysis showed PP at 1 year for was 91% Caucasian
patients vs 77% for non-Caucasian (P = .001). PP was 75%
in patients aged <60 years, 86% in patients aged 60-70
years, and 96% in patients aged >70 years, with a sig-
niﬁcant difference between all groups (P < .001). PP was
signiﬁcantly different for those with and without EIA
occlusion (P = .002), with 1-year PP of 71% and 88%,
respectively.
Conclusions: In our experience with a large number of iliac
interventions, younger age, non-Caucasian race, and EIA
occlusion were strong predictors for loss of PP.Dynamic muscle quality of the plantar ﬂexors is impaired
in claudicant patients with peripheral arterial disease and
associated with poorer walking endurance
Stephanie King, MSc, Natalie Vanicek, PhD, and Thomas
D. O’Brien, PhD
Objective: Peripheral arterial disease and intermittent clau-
dication (PAD-IC) negatively affects physical activity and
function. There is evidence for plantarﬂexor muscle dys-
function and weakness; however, the extent to which this
dysfunction can be attributed to reduced muscle size or
quality, or both, is not yet known. This study investigated
whether in vivo plantarﬂexor muscle quality during static and
dynamic contractions is altered by PAD-IC and whether such
changes are associated with impaired walking endurance
according to initial and absolute claudication distances.
Methods: The study recruited 22 participants, consisting of
10 healthy controls and 12 claudicant patients with occlusion
of the superﬁcial femoral artery (seven unilateral and ﬁve
bilateral). Muscle quality of the combined gastrocnemius
muscles during static contractions was calculated by nor-
malizing the estimatedmaximal potential muscle force to the
physiological cross-sectional area of the lateral and medial
gastrocnemius. Muscle quality during dynamic contractions
of the combined plantarﬂexor muscles was calculated as the
ratio of peak voluntary concentric plantarﬂexor power and
the summed volume of lateral and medial gastrocnemius.
Results: Dynamic muscle quality was 24% lower in the clau-
dicating-limb and asymptomatic-limb groups compared with
controls (P = .017 and P = .023). The differences were most
apparent at the highest contraction velocity (180/s).
Dynamicmuscle quality was associatedwith reducedwalking
endurance (R = 0.689, P = .006 and R = 0.550, P = .042 for
initial and absolute claudication distance, respectively). The
claudicating-limb group demonstrated a trend toward
reduced staticmuscle quality comparedwith controls (22%, P
= .084). The relative contribution of the soleus muscle to
plantarﬂexion maximum voluntary contraction was sig-
niﬁcantly higher in the claudicating-limb and asymptomatic-
limb groups than in controls (P = .012 and P = .018).
Conclusions: The muscle strength of the plantarﬂexors in
those with PAD-IC appears to be impaired at high contraction
velocities. This may be explained by some reduction in gas-
trocnemii muscle quality and a greater reliance on the prom-
inently type I-ﬁbered soleus muscle. The reduced dynamic
capability of the plantarﬂexor muscles was associated with
disease severity and walking ability; therefore, efforts to
improve plantarﬂexor power through dynamic exercise inter-
vention are vital to maintain functional performance.
